Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 1.92 CAD -2.54% Market Closed
Market Cap: 53m CAD

Covalon Technologies Ltd
Other Long-Term Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Covalon Technologies Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Other Long-Term Assets
CA$11.6k
CAGR 3-Years
-32%
CAGR 5-Years
-55%
CAGR 10-Years
-12%
Theratechnologies Inc
TSX:TH
Other Long-Term Assets
$190k
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Other Long-Term Assets
$600k
CAGR 3-Years
-58%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Other Long-Term Assets
$93k
CAGR 3-Years
-81%
CAGR 5-Years
-14%
CAGR 10-Years
-1%
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Other Long-Term Assets
$18.9m
CAGR 3-Years
235%
CAGR 5-Years
107%
CAGR 10-Years
27%
Spectral Medical Inc
TSX:EDT
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
52.6m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.7 CAD
Undervaluation 29%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Other Long-Term Assets?
Other Long-Term Assets
11.6k CAD

Based on the financial report for Jun 30, 2025, Covalon Technologies Ltd's Other Long-Term Assets amounts to 11.6k CAD.

What is Covalon Technologies Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
-12%

Over the last year, the Other Long-Term Assets growth was -95%. The average annual Other Long-Term Assets growth rates for Covalon Technologies Ltd have been -32% over the past three years , -55% over the past five years , and -12% over the past ten years .

Back to Top